| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |